[email protected] +91 9789129171
ISOIB · Registering as Listener

International Symposium on Oncology, Immunotherapy and Biomarkers

3 - 4 Mar 2027 Warsaw, Poland Standard / Physical Participation
Listener Registration
$125
virtual · $155 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceISOIB
ModeStandard / Physical
ParticipationListener
Registration fee$155.00
Bank charges (5.8%)$8.99
Total payable$163.99
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

ISOIB conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities
01 Advancements in Immunotherapy for Cancer Treatment +
This track will explore the latest breakthroughs in immunotherapy, focusing on novel therapeutic agents and their mechanisms of action. Discussions will include clinical trial outcomes and the integration of immunotherapy into standard cancer treatment protocols.
02 Biomarkers in Cancer Diagnosis and Prognosis +
This session will delve into the role of biomarkers in enhancing cancer diagnosis and predicting patient outcomes. Researchers will present findings on the identification and validation of biomarkers across various cancer types.
03 Precision Medicine in Oncology +
This track will examine the principles and applications of precision medicine in oncology, emphasizing personalized treatment strategies based on genetic and molecular profiling. Case studies will illustrate the impact of tailored therapies on patient care.
04 Tumor Microenvironment and Cancer Progression +
This session will investigate the interactions between tumor cells and their microenvironment, highlighting how these relationships influence cancer progression and metastasis. Presentations will cover both experimental and clinical insights into tumor biology.
05 Translational Oncology: Bridging Research and Clinical Practice +
This track will focus on the translation of laboratory findings into clinical applications, addressing the challenges and successes of moving from bench to bedside. Participants will discuss innovative approaches to enhance the efficacy of cancer therapies.
06 Health Policy and Access to Cancer Care +
This session will explore the impact of health policy on cancer treatment accessibility and quality of care. Experts will discuss strategies to improve healthcare delivery and address disparities in cancer treatment across populations.
07 Emerging Trends in Cancer Biology +
This track will highlight the latest research in cancer biology, focusing on novel pathways and mechanisms that drive tumorigenesis. Presentations will cover cutting-edge studies that may lead to new therapeutic targets.
08 Combination Therapies in Oncology +
This session will examine the rationale and effectiveness of combination therapies in cancer treatment. Researchers will present data on synergistic effects of combining different modalities, including chemotherapy, immunotherapy, and targeted therapies.
09 Pediatric Oncology: Unique Challenges and Innovations +
This track will address the specific challenges faced in pediatric oncology, including treatment side effects and long-term outcomes. Innovative approaches and recent advancements in the treatment of childhood cancers will be discussed.
10 Clinical Trials: Design and Implementation in Oncology +
This session will focus on the design and execution of clinical trials in oncology, emphasizing best practices and regulatory considerations. Participants will share insights on improving patient recruitment and retention in cancer studies.
11 Future Directions in Cancer Research +
This track will explore emerging trends and future directions in cancer research, including novel therapeutic approaches and technologies. Experts will discuss the potential impact of artificial intelligence and big data on oncology.